DaShenLin Pharmaceutical Group Co., Ltd.
603233
Rank in Stocks
#4889
Established in 1999, DaShenLin Pharmaceutical Group Co., Ltd. is a Chinese... Established in 1999, DaShenLin Pharmaceutical Group Co., Ltd. is a Chinese company based in Guangzhou. It operates across the pharmaceutical supply chain, engaging in the production, distribution, and direct sale of medicinal products throughout the country.
Share Price
$2.64
Market Cap
$3.01B
Change (1 day)
-4.30%
Change (1 year)
2.39%
Country
CN
Trade DaShenLin Pharmaceutical Group Co., Ltd. (603233)
Category
Healthcare
Earnings for DaShenLin Pharmaceutical Group Co., Ltd. (603233)
Earnings in Jun 2026 TTM: $296.94M
According to DaShenLin Pharmaceutical Group Co., Ltd. latest financial reports the company's current earnings are $296.94M. In 2023 the company made an earning of $229.96M, an increase over its 2022 earnings that were of $205.12M. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for DaShenLin Pharmaceutical Group Co., Ltd. from 2012 to 2026
Earnings at the end of each year
| Year | Earnings | Change |
|---|---|---|
| 2026 (TTM) | $296.94M | 61.79% |
| 2024 | $183.54M | -20.19% |
| 2023 | $229.96M | 12.11% |
| 2022 | $205.12M | 24.89% |
| 2021 | $164.24M | -25.82% |
| 2020 | $221.41M | 67.67% |
| 2019 | $132.05M | 26.23% |
| 2018 | $104.61M | 7.25% |
| 2017 | $97.53M | 17.26% |
| 2016 | $83.17M | -2.54% |
| 2015 | $85.34M | 24.77% |
| 2014 | $68.40M | 29.00% |
| 2013 | $53.02M | 35.78% |
| 2012 | $39.05M | 0.00% |
Earnings for similar companies or competitors
| Company | Earnings | Earnings Difference | Country |
|---|---|---|---|
| $5.27B | 1,676.42% |
US
|
|
| $-3.09B | -1,139.60% |
US
|
|
| $-4.02B | -1,452.53% |
AU
|
|
| - | - |
CH
|
|
| $1.95B | 556.92% |
NL
|
